| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.099 | 0.09 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.084 | 0.09 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |